Coronavirus 2019, Microthromboses, and Platelet Activating Factor.
Clin Ther
; 42(10): 1850-1852, 2020 10.
Article
in English
| MEDLINE | ID: covidwho-743922
ABSTRACT
Recent articles have reported elevated markers of coagulation, endothelial injury, and microthromboses in lungs from deceased patients with coronavirus 2019 (COVID-19). Platelets are critical in the formation of thrombi, and their most potent trigger is platelet activating factor (PAF). PAF is produced by cells involved in host defense, and its biological actions bear similarities with COVID-19 disease manifestations, including pulmonary microthromboses and inflammation, possibly via activation of mast cells. The histamine1 receptor antagonist rupatadine was developed to have anti-PAF activity and inhibits activation of human mast cells in response to PAF. Rupatadine could be repurposed for COVID-19 prophylaxis.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Pneumonia, Viral
/
Thrombosis
/
Platelet Activating Factor
/
Coronavirus Infections
/
Pandemics
Limits:
Humans
Language:
English
Journal:
Clin Ther
Year:
2020
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS